Log In
BCIQ
Print this Print this
 

naloxone nasal spray

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionOpioid antagonist nasal spray
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard Indication Neurology (unspecified)
Indication DetailsTreat opioid overdose; Treat suspected opioid overdose
Regulatory Designation U.S. - Fast Track (Treat suspected opioid overdose);
U.S. - Priority Review (Treat opioid overdose)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/19/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today